1-3 of 3
Jorge Alamo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Age Does Not Influence Long-Term Quality of Life (QOL) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for AML/MDS.

Munir Shahjahan, Jorge Alamo, Sergio Giralt, Michelle Detry, Mark Munsell, Elihu Estey, Richard Champlin, Marcos de Lima
Journal: Blood
Blood (2004) 104 (11): 2193.
https://doi.org/10.1182/blood.V104.11.2193.2193
Published: 2004
Journal Articles

IV Busulfan (Bu) with Fludarabine (Flu) or Cyclophosphamide (Cy) - Comparing Ablative Conditioning Regimens for Allogeneic Transplantation in AML/MDS.

Marcos de Lima, Daniel Couriel, Munir Shahjahan, Jorge Alamo, Peter F. Thall, James Russell, Paolo Anderlini, Sergio Giralt, Elizabeth J. Shpall, Roy B. Jones, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2004) 104 (11): 97.
https://doi.org/10.1182/blood.V104.11.97.97
Published: 2004
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients Aged 65 Years or Older with AML and MDS.

Marcos de Lima, Munir Shahjahan, Jorge Alamo, Patricia Williams, Brigitte von Wolff, Daniel Couriel, Issa Khouri, Gabriela Rondon, Brandy Wheeler, Elihu Estey, Naoto Ueno, Partow Kebriaei, Richard Champlin, Sergio Giralt
Journal: Blood
Blood (2004) 104 (11): 2301.
https://doi.org/10.1182/blood.V104.11.2301.2301
Published: 2004